Article Per Year (5 Year)
p-Index From 2021 - 2026
0.444
P-Index
This Author published in this journals
All Journal Jurnal Farmasi Klinik - Best Practice (JFKlin)
Sinukaban, Satriani
Unknown Affiliation
Chemistry Health Professions Immunology & microbiology Medicine & Pharmacology Public Health

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

 1 
Evaluation Of The Use Of Cyclophosphamide In Children Diagnosed With Steroid Resistant Nephrotic Syndrome Treated In The 3rd Floor Treatment At Fatmawati Hospital Sinukaban, Satriani; Setiadi Darmawan, Bobby
Jurnal Farmasi Klinik Best Practice Vol 1 No 1 (2022): Jurnal Farmasi Klinik - Best Practice
Publisher : RSUP Fatmawati

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.58815/jfklin.v1i1.14

Abstract

A total of 32 children with nephrotic syndrome were treated with cyclophosphamide, the remissions and side effects that often occurred during therapy were counted. This research was conducted using a retrospective descriptive method. The results showed that the remission was 59.4%. The mean duration of the call to remission was 14 weeks and the mean dose of cyclophosphamide was 589 mg. As many as 59.4% of patients experienced no side effects, while 40.6% experienced side effects. Side effects that occurred included vomiting (3.1%); nausea (3.1%); hair loss (6.3%); nausea and vomiting (12.5%); vomiting and hair loss (6.3%); nausea and hair loss (6.3%); and nausea, vomiting, and hair loss (3.1%). Keywords: Steroid-Resistant Nephrotic Syndrome, Cyclophosphamide
Gambaran Efek Samping Obat Sitotoksik pada Pasien Kanker yang Menjalani Kemoterapi di RSUP Fatmawati Jakarta 2023 Sinukaban, Satriani
Jurnal Farmasi Klinik Best Practice Vol 3 No 1 (2024): Jurnal Farmasi Klinis Best Practice Volume 3 No. 1 Juni 2024
Publisher : RSUP Fatmawati

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.58815/jfklin.v3i1.41

Abstract

Cancer is a non-communicable disease which is characterized by uncontrolled cell division in the body. In 2022 in Indonesia, breast cancer will rank first at 16.2%, followed by lung cancer at 9.5%, then cervical cancer at 9%, colorectal cancer at 8.7%, liver cancer at 5.8%, and other cancers at 50.7%. One of the treatment methods in Patients suffering from cancer receive chemotherapy. Chemotherapy is a treatment using drugs that can inhibit or kill cancer cells which involves a combination of two or more drugs that are cytotoxic and can cause side effects in patients, which is usually called DRP (drug related problem). This research aims to find out the picture side effects of cytotoxic drugs in patients undergoing chemotherapy. This research was carried out using a descriptive retrospective method, using MESO pharmacist report data in the cancer center room and there were 38 patients who experienced side effects from cytostatic drugs. Of the 38 patients, the largest disease was ovarian cancer, 13 of them, the most frequently used therapy regimen was a combination of Paclitaxel and Carboplatin, 15, the most common side effect experienced by chemotherapy patients was dyspnea which occurred in 21 patients. And the antidote that is often used is Dexamethasone injection in 27 cases.
Co-Authors Setiadi Darmawan, Bobby